May modifications of human plasma proteins stimulated by homocysteine and its thiolactone induce changes of hemostatic function of plasma in vitro?

General Physiology and Biophysics

Volumn 29, Issue 2, 2010, Pages 186-193

  Olas, Beata ^a   Kołodziejczyk, Joanna ^a   Malinowska, Joanna ^a  

^a UNIVERSITY OF LODZ   (Poland)

Author keywords

Homocysteine; Homocysteine thiolactone; Plasma; Proteins

Indexed keywords

ALBUMIN; AMINO ACID; FIBRINOGEN; HEMOGLOBIN; HOMOCYSTEINE; PLASMA PROTEIN; THIOLACTONE; HOMOCYSTEINE THIOLACTONE; THIOL DERIVATIVE;

ARTICLE; BLOOD CLOTTING; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; IN VITRO STUDY; INCUBATION TIME; PLASMA; PROTHROMBIN TIME; THROMBIN TIME; ACYLATION; ADULT; ANALOGS AND DERIVATIVES; BLOOD; CHEMISTRY; DRUG EFFECTS; METABOLISM;

ACYLATION; ADULT; BLOOD COAGULATION; BLOOD PROTEINS; HEMOSTASIS; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; IN VITRO TECHNIQUES; SULFHYDRYL COMPOUNDS;

EID: 77954133782     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2010_02_186     Document Type: Article

References (41)

1. Ando Y., Steiner M. (1973a): Sulfhydryl and disulfide groups of platelet membranes. II. Determination of sulfhydryl groups. Biochim. Biophys. Acta 311, 38-44; doi:10.1016/0005-2736(73)90252-6
2. Ando Y., Steiner M. (1973b): Sulfhydryl and disulfide groups of platelet membranes. I. Determination of disulfide groups. Biochim. Biophys. Acta 311, 26-37; doi:10.1016/0005-2736(73)90251-4
3. Bald E., Chwatko G., Glowacki R., Kusmierek K. (2004): Analysis of plasma thiols by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 1032, 109-115; doi:10.1016/j.chroma.2003.11.030
4. Bogers R. P., Dagnelie P. C., Bast A., van Leeuwen M., van Klaveren J. D., van den Brandt P. A. (2007): Effect of increased vegetable and fruit consumption on plasma folate and homocysteine concentrations. Nutrition 23, 97-102; doi:10.1016/j.nut.2006.11.002
5. Boysen G., Brander T., Christensen H., Gideon R., Truelsen T. (2003): Homocysteine and risk of recurrent stroke. Stroke 34, 1258-1261; doi:10.1161/01.STR.0000069017.78624.37
6. Chwatko G., Jakubowski H. (2005a): The determination of homocysteine-thiolartone in human plasma. Anal. Biochem. 337, 271-277; doi:10.1016/j.ab.2004.11.035
7. Chwatko G., Jakubowski H. (2005b): Urinary extraction of homocysteine thiolactone in humans. Clin. Chem. 51, 408-415; doi:10.1373/clinchem.2004.042531
8. D'Angelo A., Selhub J. (1997): Homocysteine and thrombotic disease. Blood 90, 1-11
9. Ferretti G., Bacchetti T., Moroni C., Vignini A., Nanetti L., Curatola G. (2004): Effect of homocysteinylation of low density lipoproteins on lipid peroxidation of human endothelial cells. J. Cell. Biochem. 92, 351-360; doi:10.1002/jcb.20069
10. Ferretti G., Bacchetti T., Rabini R. A., Vignini A., Nanetti L., Moroni C., Mazzanti L. (2006): Homocysteinylation of low-density lipoproteins (LDL) from subjects with Type 1 diabetes: effect on oxidative damage of human endothelial cells. Diabet. Med. 23, 808-813; doi:10.1111/j.1464-5491.2006.01809. x
11. Glowacki R., Wójcik K., Bald E. (2001): Facile and sensitive method for the determination of mesna in plasma by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 914, 29-35; doi:10.1016/S0021-9673(00)01064-5
12. Harpel P. C., Chang V. T., Borth W. (1992): Homocysteine and other sulfydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfydryl compound metabolism. Proc. Natl. Acad. Sci. USA 89, 10193-10197; doi:10.1073/pnas.89.21. 10193
13. Harpel P. C., Zhang X., Borth W. (1996): Homocysteine and hemostasis: pathogenic mechanisms predisposing to thrombosis. J. Nutr. 126, S1285-1289
14. Hop C. E., Bakhtiar R. (2002): Homocysteine thiolactone and protein homocysteinylation: mechanistic studies with model peptides and proteins. Rapid Commun. Mass Spectrom. 16, 1049-1053; doi:10.1002/rcm.681
15. Jakubowski H. (1999): Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels. FASEB J. 13, 2277-2283
16. Jakubowski H., Zhang L., Bardeguez A., Aviv A. (2000): Homocysteine thiolactone and protein homocysteinylation in human endothelial cells: implications for atherosclerosis. Circ. Res. 87, 45-51
17. Jakubowski H. (2001): Protein N-homocysteinylation: implications for atherosclerosis. Biomed. Pharmacother. 55, 443-447; doi:10.1016/S0753-3322(01) 00085-3
18. Jakubowski H. (2002): Homocysteine is a protein amino acid in humans. Implications for homocysteine-linked disease. J. Biol. Chem. 277, 30425-30428; doi:10.1074/jbc.C200267200
19. Jakubowski H. (2006): Mechanism of the condensation of homocysteine thioladone with aldehydes. Chemistry 12, 8039-8043; doi:10.1002/chem.200600785
20. Lauricella A. M., Quintana I. L., Kordich L. C. (2002): Effects of homocysteine thiol group on fibrin networks: Another possible mechanism of harm. Thromb. Res. 107, 75-79; doi:10.1016/S0049-3848(02)00191-3
21. Lauricella A. M., Quintana I., Castanon M., Sassetti B., Kordich L. (2006): Influence of homocysteine on fibrin network lysis. Blood Coagul. Fibrinolysis 17, 181-186; doi:10.1097/01.mbc.0000220238.99843.45
22. Levine R. L., Wehr N., Williams J. A., Stadtman E. R., Shacter E. (2000): Determination of carbonyl groups in oxidized proteins. Methods Mol. Biol. 99, 15-24
23. Li Z., Sun L., Zhang H., Liao Y., Wang D., Zhao B., Zhu Z., Zhao J., Ma A., Han Y. (2003): Elevated plasma homocysteine was associated with hemorrhagic and ischemic stroke, but methylenetetrahydrofolate reductase gene C677T polymorphism was a risk factor for thrombotic stroke: a Multicenter Case-Control Study in China. Stroke 34, 2085-2090; doi:10.1161/01.STR.0000086753.00555.0D
24. Mansoor M. A., Svardal A. M., Ueland P. M. (1992): Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal. Biochem. 200, 218-229; doi:10.1016/0003- 2697(92)90456-H
25. Olas B., Kedzierska M., Wachowicz B. (2008): Comparative studies on homocysteine and its metabolite - homocysteine thioladone action in blood platelets in vitro. Platelets 19, 520-527; doi:10.1080/09537100802308081
26. Olas B., Kołodziejczyk J., Kedzierska M., Rywaniak J., Wachowicz B. (2009): Modification of human blood platelet proteins induced by homocysteine and its thiolactone in vitro. Thromb. Res. 124, 689-694; doi:10.1016/j. thromres.2009.06.026
27. Perla-Kajan J., Twardowski T., Jakubowski H. (2007): Mechanisms of homocysteine toxicity in humans. Amino Acids 32, 561-572; doi:10.1007/s00726- 006-0432-9
28. Ramakrishnan S., Sulochana K. N., Lakshmi S., Selvi R., Angayarkanni K. (2006): Biochemistry of homocysteine in health and diseases. Indian J. Biochem. Biophys. 43, 275-283
29. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., Porcellini E., Licastro F. (2005): Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am. J. Clin. Nutr. 82, 636-664
30. Rossi R., Giustarini D., Milzani A., Dalle-Donne I. (2008): Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J. Cell. Mol. Med. 13, 3131-3140; doi:10.1111/j.1582-4934. 2008.00417.x
31. Sashidhar R. B., Capoor A. K., Ramana D. (1994): Quantitation of epsilon-amino group using amino acids as reference standards by trinitrobenzene sulfonic acid. A simple spectrophotometric method for the estimation of hapten to carrier protein ratio. J. Immunol. Methods 167, 121-127; doi:10.1016/0022- 1759(94)90081-7
32. Sauls D. L., Wolberg A. S., Hoffman M. (2003): Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J. Thromb. Haemost. 1, 300-306; doi:10.1046/j.1538-7836.2003.00053.x
33. Sauls D. L., Lockhart E., Warren M. E., Lenkowski A., Wilhelm S. E., Hoffman M. (2006): Modification of fibrinogen by homocysteine thioladone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia. Biochemistry 45, 2480-2488; doi:10.1021/bi052076j (Pubitemid 43297307)
34. Sauls D. L., Arnold E. K., Bell C. W., Allen J. C., Hoffman M. (2007): Pro-thrombotic and pro-oxidant effects of diet-induced hyperhomocysteinemia. Thromb. Res. 120, 117-126; doi:10.1016/j.thromres.2006.08.001
35. Sengupta S., Chen H., Togawa T., Di Bello P. M., Majors A. K., Budy B., Ketterer M. E., Jacobsen D. W. (2001): Albumin thiolate anion is an intermediate in the formation of albumin-S-S-homocysteine. J. Biol. Chem. 276, 30111-30117; doi:10.1074/jbc.M104324200
36. Togawa T., Sengupta S., Chen H., Robinson K., Nonevski I., Majors A. K., Jacobsen D. W. (2000): Mechanisms for the formation of protein-bound homocysteine in human plasma. Biochem. Biophys. Res. Commun. 277, 668-674; doi:10.1006/bbrc.2000.3723
37. Undas A., Williams E. B., Butenas S., Orfeo T., Mann K. G. (2001): Homocysteine inhibits inactivation of factor Va by activated protein C. J. Biol. Chem. 276, 4389-4397; doi:10.1074/jbc.M004124200
38. Undas A., Brozek J., Jankowski M., Siudak Z., Szczeklik A., Jakubowski H. (2006): Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects. Arterioscler. Thromb. Vasc. Biol. 26, 1397-1404; doi:10.1161/01.ATV.0000219688.43572.75
39. Wolen R. L., Wriston J. C. (1963): On the oxidation of D-1, 3-thiazane-4-carboxylic acid (D-tetrahydro-1,3-thiazine-4-carboxylic acid). J. Biol. Chem. 238, 377-380
40. Wriston J. C., Mackenzie C. G. (1957): Synthesis and metabolism of 1,3-thiazane-4-carboxylic acid derived from formaldehyde and homocysteine. J. Biol. Chem. 225, 607-613
41. Zou C. G., Banerjee R. (2005): Homocysteine and redox signaling. Antioxid. Redox Signal. 7, 547-559; doi:10.1089/ars.2005.7.547